Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) |
Date | Article Title | Journal |
|---|---|---|---|
|
Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh |
June 2016 | Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel | European Urology |
|
Hani Oweira, Anway Giryes, Meinrad Mannhart, Michael Decker, and Omar Abdel-Rahman |
August 2018 | Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials | Expert Review of Gastroenterology and Hepatology |
|
Hirotaka Miyashita, Christina Cruz, Cardinale Smith |
August 2020 | Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial | Supportive Care in Cancer |
|
Hirotaka Miyashita, Christina Cruz, Stephen Malamud |
May 2020 | Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate | Breast Cancer Research and Treatment |
|
Hirotaka Miyashita, Christina Cruz, Vaibhav Patel |
August 2021 | Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate | Supportive Care in Cancer |
|
Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates |
April 2019 | Resistance Models to EGFR Inhibition and Chemotherapy in Non-Small Cell Lung Cancer Via Analysis of Tumour Size Dynamics | Cancer Chemotherapy and Pharmacology |
|
Jean Coquet, PhD; Nicolas Bievre, MS; Vincent Billaut, MS; Martin Seneviratne, MD; Christopher J. Magnani, MPhil; Selen Bozkurt, PhD; James D. Brooks, MD; Tina Hernandez-Boussard, PhD |
February 2021 | Assessment of a Clinical Trial–Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer | JAMA Network Open |
|
Jeffrey West, Yongqian Ma, Paul K. Newton |
October 2018 | Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment | Journal of Theoretical Biology |
|
Jiawei Zhou, Quefeng Li, Yanguang Cao |
February 2021 | Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer | Cancer Research |
|
Jiawei Zhou, Yutong Liu, Yubo Zhang, Quefeng Li and Yanguang Cao |
November 2019 | Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer; a retrospective analysis | American Association for Cancer Research |
|
Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs |
December 2021 | Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response | Statistics in Medicine |
|
Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang |
June 2018 | Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study | Cancer Medicine |
|
Justin Guinney, Tao Wang, Teemu D. Laajala, Kimberly Kanigel Winner, J. Christopher Bare, Elias Chaibub Neto, Suleiman A. Khan, Gopal Peddinti, Antti Airola, Tapio Pahkkala, Tuomas Mirtti, Thomas Yu, Brian M. Bot, Liji Shen, Kald Abdallah, Thea Norman, Stephen Friend, Gustavo Stolovitzky, Howard Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Yang Xie, Tero Aittokallio, Fang Liz Zhou, James C. Costello |
January 2017 | Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data | The Lancet Oncology |
|
Justyna Mierzynska, Mekdes Taye, Madeline Pe, Corneel Coens, Francesca Martinelli, Katarzyna Pogoda, Galina Velikova, Vesna Bjelic-Radisic, Fatima Cardoso, Etienne Brain, Michail Ignatiadis, Martine Piccart, Geertjan Van Tienhoven, Robert Mansel, Hans Wildiers, Andrew Bottomley, on behalf of EORTC and EORTC Breast Cancer Group |
December 2019 | Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer | European Journal of Cancer |
